Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6307733d0b7b0574c82cb0051e06cc0c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-01 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate |
2017-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_000353d8b25dbdf9021c880bc97a5482 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bd898190dd93ca3ad565dd7979c9495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e3bda8db052b5b94b4a3d28e438baa7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72f5949d7d3d7691c12c708d939410d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_977ce03d4c18bc22ed3e31b7bc541e9a |
publicationDate |
2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9850519-B1 |
titleOfInvention |
Method for producing alpha-glucosidase inhibitors utilizing Paenibacillus sp |
abstract |
A method for producing alpha-glucosidase inhibitors utilizing Paenibacillus sp., wherein utilizing a Paenibacillus sp. strain which is deposited at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSMZ) and numbered No. DSM 32521 to produce the alpha-glucosidase inhibitors, the Paenibacillus sp. Strain is cultivated in a commercial culture medium or a shrimp/crab residue-contained culture medium, and the alpha-glucosidase inhibitors is separated from a fermented supernatant. The alpha-glucosidase inhibitors have strong inhibitory activity. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111349685-A |
priorityDate |
2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |